Surgical Science Bundle
Who Really Controls Surgical Science?
Understanding the ownership structure of a company is crucial for investors and stakeholders alike. Surgical Science, a leader in Surgical Science SWOT Analysis and medical simulation, recently made waves with its acquisition of Intelligent Ultrasound Group. This strategic move, along with the company's innovative approach to healthcare technology, makes its ownership a key area of interest.
This article will explore the intricate details of Surgical Science ownership, from its roots as Surgical Science AB in 1999 to its current position in the market. We'll analyze the influence of major shareholders, the dynamics of the Board of Directors, and the implications of recent developments on the Surgical Science stock price and overall strategy. Discover the key players behind this innovative company and gain insights into its future trajectory, including its competitors and recent financial reports.
Who Founded Surgical Science?
The origins of Surgical Science Sweden AB trace back to 1999. The company's foundation was rooted in research and development focused on virtual reality simulation, specifically designed for medical training. While the precise details regarding the founders' names and initial equity distribution are not readily available in the provided information, the company's early focus set the stage for its future in healthcare technology.
The early years saw Surgical Science transition from a research-oriented entity to a commercial growth company. This transition gained significant momentum, particularly from 2016 onward. Although the specific involvement of angel investors or early financial backers isn't detailed, the company's development in a specialized and technologically advanced field suggests that early financial support played a crucial role. The absence of explicit information on early agreements, such as vesting schedules or founder exit strategies, is noted, but the company's long-term growth strategy has involved strategic acquisitions, which would naturally have reshaped early ownership interests over time.
The evolution of Surgical Science highlights the dynamic nature of ownership in the tech and healthcare sectors. The company's journey from its inception to its current status reflects strategic shifts and adaptations in response to market opportunities and technological advancements. The company's growth trajectory, including its strategic acquisitions, has likely led to changes in the ownership structure over time.
Key Aspects of Surgical Science's Early Ownership
Understanding the early ownership structure of Surgical Science provides insights into the company's foundational years and its subsequent growth. The company's focus on medical simulation, a niche within healthcare technology, required specialized expertise and likely attracted investors interested in long-term growth. The absence of detailed information on the founders and initial equity splits, common in early-stage companies, underscores the need for further research to fully understand the company's origins.
- Founding Year: Surgical Science Sweden AB was founded in 1999.
- Initial Focus: Research and development in virtual reality simulation for medical training.
- Ownership Evolution: The company transitioned from a research-focused entity to a commercial growth company, especially after 2016.
- Strategic Acquisitions: The company's growth strategy has involved strategic acquisitions, which have reshaped early ownership interests. For a deeper understanding of the competitive environment, explore the Competitors Landscape of Surgical Science.
Surgical Science SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Surgical Science’s Ownership Changed Over Time?
Understanding the ownership structure of Surgical Science is crucial for investors and stakeholders. Surgical Science Sweden AB, a key player in the medical simulation industry, is a publicly traded company. Its shares are listed on the Nasdaq First North Growth Market in Stockholm. As of June 12, 2025, the company's market capitalization reached approximately $817 million, with a total of 51 million shares outstanding. This structure allows for public investment and reflects the company's growth and market position.
Several strategic acquisitions have reshaped Surgical Science's ownership landscape. The acquisition of SenseGraphics in 2019 marked an early expansion. This was followed by the acquisition of Mimic Technologies in early 2021 and Simbionix later that year. Most recently, in February 2025, Surgical Science completed the acquisition of Intelligent Ultrasound Group. These moves have significantly broadened Surgical Science's customer base, expanded its technology offerings, and strengthened its presence in the medical simulation market, particularly in areas like robotic surgery and ultrasound simulation. To learn more about the company's journey, you can read a Brief History of Surgical Science.
| Shareholder | Percentage (Feb 2025) | Shares |
|---|---|---|
| Marknadspotential AB | 13.99% | 7,138,371 |
| RBE Konsult AB | 11.74% | 5,992,338 |
| Fjärde AP-fonden | 5.579% | 2,846,630 |
| Kirkbi Invest A/S | 4.999% | 2,550,961 |
| Teknik Innovation Norden Fonder AB | 4.338% | 2,213,609 |
The major stakeholders in Surgical Science include a mix of significant individual shareholders and institutional investors. As of February 2025, key shareholders include Marknadspotential AB with 13.99%, and RBE Konsult AB with 11.74%. Other notable shareholders include Fjärde AP-fonden, Kirkbi Invest A/S, and Teknik Innovation Norden Fonder AB. Institutional investors, as of late 2024, include Montanaro Asset Management Ltd., BlackRock, Inc., and Phoenix Asset Management Partners Ltd. These ownership dynamics, driven by both acquisitions and public market activities, have directly influenced the company's strategic direction, enabling broader product offerings and a wider global reach.
Key Takeaways on Surgical Science Ownership
Surgical Science is a publicly traded company with a market cap of approximately $817 million as of June 12, 2025.
- Strategic acquisitions have significantly shaped the company's ownership structure and market presence.
- Major shareholders include Marknadspotential AB and RBE Konsult AB, among others.
- Institutional investors like Montanaro Asset Management Ltd. also hold significant stakes.
- The ownership structure impacts the company's strategy and global reach.
Surgical Science PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Surgical Science’s Board?
The governance of Surgical Science, a Swedish public limited company, is structured around its general meeting, board of directors, managing director, and senior executives. The company operates in accordance with the Swedish Companies Act and its articles of association. Understanding the board's composition and the distribution of voting power is crucial for investors and stakeholders interested in Surgical Science ownership.
As of May 2025, the Chairman of the Board is Gisli Hennermark, who previously served as CEO from 2015 to 2024. Roland Bengtsson, a board member since 2005 and former Chairman from 2017 to 2025, holds a significant shareholding through companies. Jan Bengtsson, another major owner through Marknadspotential AB, also plays a key role in the ownership structure. The board is composed of members representing major shareholders and individuals with extensive industry and financial expertise. The Annual General Meeting on May 15, 2025, approved the company's financial statements for 2024 and re-elected board members. The Nomination Committee, which proposes board members, includes representatives from the largest shareholders, ensuring alignment between ownership and governance.
| Board Member | Role | Shareholding (Approximate) |
|---|---|---|
| Gisli Hennermark | Chairman of the Board | Information not publicly available |
| Roland Bengtsson | Board Member | Significant through companies |
| Jan Bengtsson | Board Member | Major owner through Marknadspotential AB |
The voting structure generally follows a one-share-one-vote principle for publicly traded shares. However, certain agreements tied to acquisitions, like the call options issued to Jeff Berkley (founder of Mimic Technologies) by Jan Bengtsson and Roland Bengtsson in early 2024, illustrate instances where specific individuals might have additional contractual rights related to share acquisition. These agreements did not dilute other shareholders upon exercise. For a detailed look at the company's strategic direction, consider reading about the Growth Strategy of Surgical Science.
Key Takeaways on Surgical Science Ownership
The board of directors at Surgical Science includes individuals with significant ownership stakes and industry experience.
- Gisli Hennermark is the current Chairman, with Roland Bengtsson and Jan Bengtsson also holding key positions.
- The voting structure is primarily one-share-one-vote, with specific agreements potentially affecting share acquisition.
- The Annual General Meeting approves financial statements and re-elects board members, with the Nomination Committee involving major shareholders.
- Understanding the board's composition is crucial for those interested in Surgical Science ownership and the company's future.
Surgical Science Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Surgical Science’s Ownership Landscape?
Over the past few years, Surgical Science has strategically acquired companies to strengthen its market position. The acquisition of Mimic Technologies in 2021 boosted its capabilities in robotic surgery simulation. In 2025, the acquisition of Intelligent Ultrasound Group further enhanced its ultrasound simulation offerings. These strategic moves have contributed to an increase in the workforce, with approximately 330 employees as of April 2025.
In the context of Surgical Science ownership, the company's focus on digitalized medical training and robotic surgery is evident. The company's revenue for the full year 2024 was SEK 884.1 million, with a gross margin of 68%. As of December 31, 2024, net cash stood at SEK 732.7 million. The first quarter of 2025 showed a 33% increase in net sales, reaching SEK 250.7 million compared to the same period in the previous year. The company's emphasis on patient safety through medical simulation is a key aspect of its strategy, along with its continued global expansion.
The company has implemented long-term incentive programs for employees, which can lead to minor dilution. An incentive program approved at the May 15, 2025 Annual General Meeting involves 370,000 warrants, resulting in a dilution of approximately 0.73% of the total shares and votes. Leadership changes include Tom Englund's appointment as CEO in July 2024, and Gisli Hennermark transitioning from CEO to Chairman of the Board in May 2025.
Key Acquisitions
Surgical Science has made strategic acquisitions, including Mimic Technologies and Intelligent Ultrasound Group. These acquisitions have expanded the company's capabilities in medical simulation. The moves have strengthened its position in the healthcare technology market.
Financial Performance
The company's revenue for 2024 was SEK 884.1 million, with a 68% gross margin. Net cash as of December 31, 2024, was SEK 732.7 million. The first quarter of 2025 saw a 33% increase in net sales.
Leadership and Ownership
Tom Englund was appointed CEO in July 2024, and Gisli Hennermark became Chairman of the Board in May 2025. Incentive programs have led to minor dilution. The company focuses on enhancing patient safety.
Strategic Focus
Surgical Science is concentrating on digitalized medical training and robotic surgery. The company continues to expand its global presence. The company's focus is on innovation in medical simulation.
Surgical Science Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What are Mission Vision & Core Values of Surgical Science Company?
- What is Competitive Landscape of Surgical Science Company?
- What is Growth Strategy and Future Prospects of Surgical Science Company?
- How Does Surgical Science Company Work?
- What is Sales and Marketing Strategy of Surgical Science Company?
- What is Brief History of Surgical Science Company?
- What is Customer Demographics and Target Market of Surgical Science Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.